These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 7083153
1. Activity of 2-fluoro-5-methylarabinofuranosyluracil against mouse leukemias sensitive to and resistant to 1-beta-D-arabinofuranosylcytosine. Burchenal JH, Chou TC, Lokys L, Smith RS, Watanabe KA, Su TL, Fox JJ. Cancer Res; 1982 Jul; 42(7):2598-600. PubMed ID: 7083153 [Abstract] [Full Text] [Related]
2. Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine. Chou TC, Burchenal JH, Schmid FA, Braun TJ, Su TL, Watanabe KA, Fox JJ, Philips FS. Cancer Res; 1982 Oct; 42(10):3957-63. PubMed ID: 7104996 [No Abstract] [Full Text] [Related]
3. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine. Lin TS, Yang JH, Liu MC, Shen ZY, Cheng YC, Prusoff WH, Birnbaum GI, Giziewicz J, Ghazzouli I, Brankovan V. J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894 [Abstract] [Full Text] [Related]
4. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs. Hong CI, Kirisits AJ, Buchheit DJ, Nechaev A, West CR. Cancer Drug Deliv; 1986 Feb; 3(2):101-13. PubMed ID: 3708534 [Abstract] [Full Text] [Related]
5. Treatment of leukemia L1210 and P388 by arabinosylcytosine-polysaccharide conjugates. Novotný L, Balázová E, Sandula J, Ujházy V, Kéry V. Int J Cancer; 1991 Jan 21; 47(2):281-4. PubMed ID: 1988371 [Abstract] [Full Text] [Related]
9. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response. Riva CM, Rustum YM. Cancer Res; 1985 Dec 21; 45(12 Pt 1):6244-9. PubMed ID: 2998596 [Abstract] [Full Text] [Related]
10. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice. Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J. Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678 [Abstract] [Full Text] [Related]
11. Nucleoside conjugates. 11. Synthesis and antitumor activity of 1-beta-D-arabinofuranosylcytosine and cytidine conjugates of thioether lipids. Hong CI, Kirisits AJ, Nechaev A, Buchheit DJ, West CR. J Med Chem; 1990 May 15; 33(5):1380-6. PubMed ID: 2329558 [Abstract] [Full Text] [Related]
13. Antitumor properties of 2(1H)-pyrimidinone riboside (zebularine) and its fluorinated analogues. Driscoll JS, Marquez VE, Plowman J, Liu PS, Kelley JA, Barchi JJ. J Med Chem; 1991 Nov 15; 34(11):3280-4. PubMed ID: 1956046 [Abstract] [Full Text] [Related]
14. Formation of 1-beta-D-arabinofuranosylcytosine diphosphate choline in neoplastic and normal cells. Lauzon GJ, Paterson AR, Belch AW. Cancer Res; 1978 Jun 15; 38(6):1730-3. PubMed ID: 274175 [Abstract] [Full Text] [Related]
17. Comparison of the antileukemic activity of 5-AZA-2'-deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-azacytidine against L1210 leukemia. Momparler RL, Momparler LF, Samson J. Leuk Res; 1984 Jun 15; 8(6):1043-9. PubMed ID: 6083417 [Abstract] [Full Text] [Related]